A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza
Status:
Completed
Trial end date:
2016-12-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and tolerability of a single dose of MEDI8852
when given with oseltamivir, the safety and tolerability of oseltamivir alone, and the safety
and tolerability of a single dose of MEDI8852 alone in adult participants with acute,
uncomplicated influenza caused by Type A strains.